Author: Ken Dropiewski

CryoLife (CRY) Announces Release Date And Teleconference Call Details For 2017 Second Quarter Financial Results

ATLANTA, July 10, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 second quarter financial results will be released on Monday, July 24, 2017 after the market closes.  On Tuesday, July 25, 2017 the Company will hold a teleconference call and live […]

Resverlogix (RVX.TO) Randomizes First Patient In Taiwan/China Portion Of The Phase III BETonMACE Clinical Trial

CALGARY, July 10, 2017 /PRNewswire/ – Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announced  that the first patient has been randomized in Taiwan in the Phase 3 BETonMACE clinical trial with lead drug apabetalone intended for high-risk patients with cardiovascular disease (“CVD”) and type 2 diabetes mellitus (“DM”). On July 8, 2015, Resverlogix and […]

Intact Vascular Release: FDA Approves 6-Month Primary Endpoint For The Tack Endovascular System In Below The Knee Disease

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint in the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial from 12 months to […]

RenalGuard Names Former St. Jude Medical (STJ)-Abiomed (ABMD) Exec as New CEO

MILFORD, MA–(Marketwired – July 10, 2017) – RenalGuard Solutions, Inc. today announced the appointment of Jim Dillon, former St. Jude Medical and Abiomed commercial executive, as Chief Executive Officer. “Jim joins RenalGuard with a proven record of executive leadership related to innovative medical devices that serve the needs of the interventional […]

CathVision Raises Venture Funding to Market New EP Recording System

COPENHAGEN, Denmark, July 7, 2017 /PRNewswire/ — Medical device company CathVision has signed a multi-million venture investment from Scandinavian-based investors VF Venture and Borean Innovation. The investment is directed at developing and market the company’s superior electrophysiology (EP) recording system for treating cardiac arrhythmia.   Approximately 2% of the Western population suffers from cardiac […]

Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies Press Release by Victoria John Creavo Medical Technologies, the UK-based med-tech company, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP […]

Cerus Endovascular Receives CE Mark Approval For The Contour Neurovascular System For The Treatment Of Intra-Cranial Aneurysms

FREMONT, Calif. and OXFORD, United Kingdom, July 6, 2017 /PRNewswire/ — Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System for the treatment of intra-cranial aneurysms (IAs) across the European Union (EU). The Contour Neurovascular System is a unique, fine mesh braid […]

LifeTech announced the launch of its global post-market surveillance study for LAmbre (TM) LAA Closure System

NEWS PROVIDED BY LifeTech Scientific Corporation 03 Jul, 2017, 11:56 BST FRANKFURT, Germany, July 3, 2017 /PRNewswire/ — On June 30, at the Congenital and Structural Intervention Congress (CSI) 2017 in Frankfurt, LifeTech Scientific Corporation (Stock Code: 1302.HK) announced the launch of a 3-year global post-market surveillance (PMS) study for the LAmbreTM Left Atrial Appendage (LAA) Closure […]

GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration

WASHINGTON–(BUSINESS WIRE)–GE Healthcare and HeartFlow, Inc. announced today at SCCT2017, the annual scientific meeting of the Society of Cardiovascular Computed Tomography, that they have entered into a global collaboration agreement with the goal of increasing the clinical availability and adoption of HeartFlow FFRct, a proprietary technology that helps clinicians diagnose and treat […]